T

Tallac Therapeutics

22 employees

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$62M

from 5 investors over 5 rounds

T

Tallac Therapeutics raised $5M on August 2, 2023

Investors: Horizon Technology Finance

T

Tallac Therapeutics raised $62M on December 1, 2020

Investors: 经纬创投(北京)投资管理顾问有限公司, venBio Partners, Lightstone Ventures and Morningside Venture Capital 晨兴资本

FAQ